|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4184 | |
| A61P 35/00 |
| (11) | Number of the document | 2131840 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08724338.2 |
| Date of filing the European patent application | 2008-03-07 | |
| (97) | Date of publication of the European application | 2009-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2018-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SG2008/000074 |
| Date | 2008-03-07 |
| (87) | Number | WO 2008/108741 |
| Date | 2008-09-12 |
| (30) | Number | Date | Country code |
| 905293 P | 2007-03-07 | US | |
| 905299 P | 2007-03-07 | US |
| (72) |
GOH, Kay Lin, SG
KHNG, Hwee Hoon, SG
SABANAYAGAM, Vasantha, Malar, MY
SANGTHONGPITAQ, Kanda, SG
STUNKEL, Walter, SG
TAN, Yong Cheng, SG
WOOD, Jeanette Marjorie, SG
|
| (73) |
MEI Pharma, Inc.,
3611 Valley Centre Drive, Suite 500, San Diego, CA 92130,
US
|
| (54) | COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT |
| COMBINATION OF BENZIMIDAZOLE ANTI-CANCER AGENT AND A SECOND ANTI-CANCER AGENT |